Changes in fibroblast growth factor 23 levels in normophosphatemic patients with chronic kidney disease stage 3 treated with lanthanum carbonate: results of the PREFECT study, a phase 2a, double blind, randomized, placebo-controlled trial

Peer Review reports

Original Submission
15 Nov 2013	Submitted	Original manuscript
4 Dec 2013	Reviewed	Reviewer Report - Bjorn Meijers
7 Dec 2013	Reviewed	Reviewer Report - Carmine Zoccali
18 Dec 2013	Reviewed	Reviewer Report - Jessica Kendrick
13 Feb 2014	Author responded	Author comments - Pablo Antonio Urena Torres
Resubmission - Version 2
13 Feb 2014	Submitted	Manuscript version 2
15 Feb 2014	Author responded	Author comments - Pablo Antonio Urena Torres
Resubmission - Version 3
15 Feb 2014	Submitted	Manuscript version 3
2 Mar 2014	Reviewed	Reviewer Report - Carmine Zoccali
4 Mar 2014	Reviewed	Reviewer Report - Bjorn Meijers
8 Mar 2014	Reviewed	Reviewer Report - Jessica Kendrick
24 Mar 2014	Author responded	Author comments - Pablo Antonio Urena Torres
Resubmission - Version 4
24 Mar 2014	Submitted	Manuscript version 4
14 Apr 2014	Author responded	Author comments - Pablo Antonio Urena Torres
Resubmission - Version 5
14 Apr 2014	Submitted	Manuscript version 5
Publishing
24 Apr 2014	Editorially accepted
5 May 2014	Article published	10.1186/1471-2369-15-71

Back to article page